BRAF and thyroid cancer: The intra-tumoral immune cell density correlates with BRAF V600E mutation and low thyroid differentiation scores, while PD-L1 positivity has been shown to correlate with lymph node metastasis, extra-nodal invasion, tumor recurrence, and poor survival in thyroid cancer patients [97].